Berisa A - Search Results

1

Candidate biomarkers in exosome-like vesicles purified from rat and mouse urine samples.

Conde-Vancells J, Rodriguez-Suarez E, Gonzalez E, Berisa A, Gil D, Embade N, Valle M, Luka Z, Elortza F, Wagner C, Lu SC, Mato JM, Falcon-Perez M. Conde-Vancells J, et al. Among authors: berisa a. Proteomics Clin Appl. 2010 Apr;4(4):416-25. doi: 10.1002/prca.200900103. Proteomics Clin Appl. 2010. PMID: 20535238 Free PMC article.

2

Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.

Gonzalez E, van Liempd S, Conde-Vancells J, Gutierrez-de Juan V, Perez-Cormenzana M, Mayo R, Berisa A, Alonso C, Marquez CA, Barr J, Lu SC, Mato JM, Falcon-Perez JM. Gonzalez E, et al. Among authors: berisa a. Metabolomics. 2012;8(6):997-1011. doi: 10.1007/s11306-011-0329-9. Epub 2011 Jul 14. Metabolomics. 2012. PMID: 23139648 Free PMC article.

3

Transcriptome of extracellular vesicles released by hepatocytes.

Royo F, Schlangen K, Palomo L, Gonzalez E, Conde-Vancells J, Berisa A, Aransay AM, Falcon-Perez JM. Royo F, et al. Among authors: berisa a. PLoS One. 2013 Jul 11;8(7):e68693. doi: 10.1371/journal.pone.0068693. Print 2013. PLoS One. 2013. PMID: 23874726 Free PMC article.

4

Chiral phosphoric acid-catalyzed Friedel-Crafts reaction of 2,5-disubstituted and 2-monosubstituted pyrroles with isoindolinone-derived ketimines.

Beriša A, Gredičak M. Beriša A, et al. Org Biomol Chem. 2023 Apr 26;21(16):3381-3387. doi: 10.1039/d3ob00326d. Org Biomol Chem. 2023. PMID: 37000532

5

Pyomyositis in children: early diagnosis and treatment.

Mitsionis GI, Manoudis GN, Lykissas MG, Sionti I, Motsis E, Georgoulis AD, Berisa AE. Mitsionis GI, et al. Among authors: berisa ae. J Pediatr Surg. 2009 Nov;44(11):2173-8. doi: 10.1016/j.jpedsurg.2009.02.053. J Pediatr Surg. 2009. PMID: 19944229

6

In vivo pharmacological characterisation of bilastine, a potent and selective histamine H1 receptor antagonist.

Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A. Corcóstegui R, et al. Among authors: berisa a. Drugs R D. 2006;7(4):219-31. doi: 10.2165/00126839-200607040-00002. Drugs R D. 2006. PMID: 16784247

7

Preclinical pharmacology of bilastine, a new selective histamine H1 receptor antagonist: receptor selectivity and in vitro antihistaminic activity.

Corcóstegui R, Labeaga L, Innerárity A, Berisa A, Orjales A. Corcóstegui R, et al. Among authors: berisa a. Drugs R D. 2005;6(6):371-84. doi: 10.2165/00126839-200506060-00005. Drugs R D. 2005. PMID: 16274260

8

Synthesis and histamine H(1)-receptor antagonist activity of 4-(diphenylmethyl)-1-piperazine derivatives with a terminal heteroaryl or cycloalkyl amide fragment.

Orjales A, Gil-Sánchez J, Alonso-Cires L, Labeaga L, Mosquera R, Berisa A, Ucelay M, Innerárity A, Corcóstegui R. Orjales A, et al. Among authors: berisa a. Eur J Med Chem. 1996;31(10):813-8. doi: 10.1016/0223-5234(96)83975-4. Eur J Med Chem. 1996. PMID: 22026937

9

Synthesis and structural, conformational, biochemical, and pharmacological study of new compounds derived from tropane-3-spiro-4'(5')-imidazoline as potential 5-HT3 receptor antagonists.

Whelan BA, Iriepa I, Galvez E, Orjales A, Berisa A, Labeaga L, Garcia AG, Uceda G, Sanz-Aparicio J, Fonseca I. Whelan BA, et al. Among authors: berisa a. J Pharm Sci. 1995 Jan;84(1):101-6. doi: 10.1002/jps.2600840123. J Pharm Sci. 1995. PMID: 7714729

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page